InspireMD Tech Stack

Mesh-covered carotid stents for stroke prevention

Medical Device Miami, Florida 51–200 employees Founded 2005 Public Company

InspireMD manufactures carotid stents using proprietary MicroNet mesh technology, with over 65,000 units sold globally. The company is in active commercial expansion: CGuard Prime launch, SwitchGuard launch, and clinical trials for regulatory submissions are concurrent workstreams. Hiring is concentrated in sales (5 open roles) alongside manufacturing and operations, reflecting a company pushing product-to-market and scaling production capacity while navigating process consolidation.

Tech Stack 10 technologies

Core StackCanva Adobe Creative Cloud Adobe Illustrator After Effects SAS Photoshop Microsoft Office Excel PowerPoint Word

What InspireMD Is Building

◆Challenges

Product launch support
Penetrating new accounts
Customer adoption
Ensuring successful product launches
Consolidating manufacturing operations
Process inefficiencies
Capacity expansion
Productivity improvement

▲Active Projects

Cguard prime launch
Product transfer and process improvement projects
Switchguard launch
Clinical trials support
Global studies for regulatory submissions
Statistical programming for regulatory submissions
Transition of new products from development to manufacturing and commercial launch
Manufacturing process improvement initiatives
Capacity expansion initiatives
Annual vendor scrub process

Hiring Activity

Decelerating10 roles · 3 in 30d

Department

Sales

Data

Design

Finance

Manufacturing

Operations

Ops

Seniority

Senior

Mid

Junior

Manager

Principal

Company intelligence

Find more companies like InspireMD by tech stack, pain points and active projects

Get started free

About InspireMD

InspireMD is a public medical device company (NASDAQ: NSPR) focused on carotid stenting for stroke prevention. The core product, CGuard Prime, is a mesh-covered carotid stent designed to reduce plaque prolapse during and after procedures. Founded in 2005 and headquartered in Miami, the company operates at commercial stage with manufacturing, clinical affairs, and sales infrastructure. Current priorities include transitioning new products from development into manufacturing and commercial launch, expanding manufacturing capacity, and supporting regulatory submissions through clinical and statistical programming.

HeadquartersMiami, Florida

Company Size51–200 employees

Founded2005

Hiring MarketsUnited States

Frequently Asked Questions

What products is InspireMD launching?

CGuard Prime (flagship mesh-covered carotid stent) and SwitchGuard are both in active launch phases, supported by concurrent clinical trials and regulatory submissions.

Where is InspireMD headquartered?

Miami, Florida. The company is public (NASDAQ: NSPR) and currently hiring only in the United States.